BioCentury
ARTICLE | Company News

Agenix, Tyrian deal

November 5, 2012 8:00 AM UTC

Agenix received exclusive, worldwide, royalty-free rights to Tyrian's DianostIQ rapid point-of-care technology for human health applications. As part of the deal, Agenix will also acquire a patent fro...